Also known as: Linzess
Linaclotide is a peptide classified under Healing & Recovery Peptides. Its full name is Linaclotide, and it functions primarily as a guanylate cyclase-C (GC-C) receptor agonist. This peptide is synthesized to aid in gastrointestinal health, particularly in the treatment of conditions like irritable bowel syndrome (IBS).
Linaclotide is designed to mimic the action of naturally occurring peptides in the body, promoting increased fluid secretion in the intestines and enhancing motility. Its specific mechanism of action makes it a valuable compound in research focused on digestive health and related disorders.
Linaclotide operates by binding to the GC-C receptors located on the intestinal epithelium. This binding activates the enzyme guanylate cyclase, leading to an increase in intracellular cyclic GMP levels. The elevated cyclic GMP enhances chloride and bicarbonate secretion into the intestinal lumen, which helps to soften stools and improve bowel movement frequency.
Linaclotide serves as a significant peptide in the realm of gastrointestinal health, primarily functioning as a GC-C receptor agonist. Its role in enhancing intestinal fluid secretion and motility underscores its relevance in research focused on digestive disorders.
Last updated: Feb 25, 2026